Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWmJLRjgwVThxc2xEaXFYcjdMeTNIU284WFQ3WHVBRTBVbFQ1S3lfSHVYZjRJb29PcFQ1QTc3NzdqUG5sV1F0SlR2d1QwekV2MUZYVXFka3Ruem1QRDA2ZEJadTgzODBNVDJSUWl3c1hIRGEzbmRkeTMwcm1nZXNscHJxUmNhM01UVzdaZk8zZjAtSVVBSnhyeEZyQVFYYzgyTkNPeGp1elpyQQ?oc=5" target="_blank">FDA Grants Fast Track Designation to Investigational Narcolepsy Treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">Sleep Review</font>
James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton
Michael Douglas confirms Charlie Sheen put ‘c---’ sign on Sean Young during Wall Street shoot
Gambhir: 'Bowlers' careers are at stake'
Tornado watches expire in SC; NWS tracked 2 confirmed tornadoes
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE5NcjRWb1VKRFRrRTB6QnVrQkZsckt0UnRZZXROUjVvTWdMVDRXVDdJU3U2cEZQeDRZVUp4VXdETXB3NHNLTktuWWVZNVNIT25NWUlOX3BwRUlJRVpBQV83RzBDY0dEa1IyTHhIYUpFaw?oc=5" target="_blank">Experimental drug reverses severe fatty liver disease by repairing the gut</a>&nbsp;&nbsp;<font color="#6f6f6f">Science Daily</font>
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOVUtMV09XU2tOXy00emRKd053NWhiSGxjOTFpbjlIR2hUM09jdExkT2NVNkt1TlVjeVM3YjJVdDdlVUI0RUFhS1hXby1mTEhwYzNuZUVZNU9ERWFfU3dzLTNMa2ZkZnRqbV9ERTZZeXBpcUhMN3dCeERaeERqSGVtN29MTU9HcFh2T0dGV2VWVDNXbDVBNTdkT0tB?oc=5" target="_blank">Novel Antidepressant Compounds From the Pipeline at ASCP</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatric Times</font>
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQTnVJRUxBM01Qb25FX3dfa0FOelFWYlFPNndHeHBCdW9ubmk5UlgteVpSRndKa1k2Z1ZKbmQzQjV3aFJLR0tHTHNxbllRQW1qZjJNdGRCeHFjd1FVNXl3U2I5dFVLd0duVTB0b0ZDSXlDS2dZakpCaFBIRTRXR0xFQkljaF9ocWIwZ1dsOUtnTUp5eG93d1dZX29VTjU2cDd3SVFFTVJaTUliQ01MLXlscQ?oc=5" target="_blank">Grünenthal receives FDA designations for tegacorat in Duchenne muscular dystrophy</a>&nbsp;&nbsp;<font color="#6f6f6f">PharmaTimes</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPdjlyMlotaDMtTF9PWGh3eG13Y1ViX3ZUWFVtcFRCLWdPYkRjWExybWtqVlFCay1BaXZCdXpWcGZWYWVVaHdIYnVxSThSRDZZcU5WbnJETUZheDlFMFFQd016WHJyaW1XUHpFVmU4TU5ISWJrbGREMG5LRmJac0M3T0o1Ui1UNHRTZ2Z0ZURiVGVsSFNkX01RbUtZVQ?oc=5" target="_blank">Bayer Announces Positive Data for Investigational PET Radiotracer</a>&nbsp;&nbsp;<font color="#6f6f6f">Imaging Technology News</font>
<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxQdG5ROHhJRFdubDFHVE1HYXhwSEkwb3JQS3NOalctXzh3eXlsQUV4Snp0eHdIU19XbnE1OFVaM0JXcGhlc3lsSnQ0OWpQbHdwVlFldWY1ck5uNkVCTG9aeGpseFZqMGRSeW1tMXhldUJEQTdMYV9WUk9LcXFRUmZYRXVkTThISkg2eVRsSkd4d0RfejhvUjgtSEVaWFlMTXJBYWVZeVRfQXBhUzFSZHNQSENhSDUySW50UW1tYVIzSFVnYzM3VkMxYjg1MHFJZ3NkMl9VRzVKQ1BCQVpWSlFGeVdIYndMU1NPWnF0blhRd0V6WTQzYU0yTVJ5ckhVdDRfbTUxcWx3N0Zua24zZXc?oc=5" target="_blank">Acta Pharma Advances GSM-779690T Phase I Trial</a>&nbsp;&nbsp;<font color="#6f6f6f">AllSci</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOaElKZHJFZER2Q0NfTmJ4OEdIUVFWbDlKc09Rdklray1IN3lOeU16eFU4U1VnSzBCY2QzYXI4ZTlBVWxqeC14Z0MxYTd3dXd3emlsblZDQmlqaFhOTFdHbXBqaVR1U3MyUVpvaXc5SUl4UVNvejQ5YmZKOFg4S1d2OEdub0NYQTgxQ2w2ckhEQjY0LVhOMGVzOG1HUk5ibkxXUDkxS1BqZWlvUQ?oc=5" target="_blank">Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy</a>&nbsp;&nbsp;<font color="#6f6f6f">Lelezard</font>
<a href="https://news.google.com/rss/articles/CBMi-AFBVV95cUxQUUxZbVFRUW9YV1lvSVhCRTJQcElUNVpoSVhHU21GRnAwcE9vWFh0Z0dzV2JRc0JQU0FuTUdVM2JLeHc3SXVYQjdVa3Z6TXloc3JUUzR0MEt6aXh5TzNFRE9tcG01SWFWbkxrdW50UndUVV8xZWpUVzN2QTJNRHA4VjQ5NGJUT0pZVi01cTJiMzBsZkg0QlVBTG1wZHdybV9fNWNrcjctM21JaktSc2NYNkJyVXJfd1Q3QXlyVTZkdVc4U0ZtSUFoTGZVa01ta01hODVrMWJtQmJZYUxJQlZHWjV1OXQ0ckRmVGZWNWg4dEhPWTRIVldJcA?oc=5" target="_blank">Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist</a>&nbsp;&nbsp;<font color="#6f6f6f">NTB Kommunikasjon</font>
<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxPdjBHUG93TVE1U2M5R1JtRmVVU0YyUmthMkRtOUlPWTRtRFJrZ2FoSEluQnRzMnFtazR5eWswYktDRWtpUThaWFJscTQyVUFtWHUxQU1kTXZtZk1zbzZXRkVUeFh2MktTOUxMOENyMGpHajE1MFdycUJWU2ZlZURIU2tzYnZDM1F0LUczLW53Wm5wTGF0Q3dBTzlJbmpkZVROQ0cyN1pQNWlHSTU2RUk5eXNPbGItbndMSXBNeno0aVprMG4yZEN1RUdBdThxRnB5SWdWaVcybWVnYzBfMDFhN1VVeUFtSWRWNWhiek5CcDI?oc=5" target="_blank">Investigational compound remdesivir, developed by UAB and NIH researchers, being used for treatment of novel coronavirus</a>&nbsp;&nbsp;<font color="#6f6f6f">The University of Alabama at Birmingham</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOQ1A4aTMzS01SVU9MWDhPb1BkVGZ6MlFiZW9ZOWZVV1ZSSUd3c0FrV1NXXzRvaThMajdaZmFSOEpmc2pNLXUtVVBvYUp4bHdnM0puSEFmamtZUlZ3VkJMdko5N05pOFBsZzR6X1ZlcUdCVjZGSkYxU1g2TjNCV2pCQ2U3WHFzRzF0RHlSekJoZFFERGYxZXpiX0xSZTRGcGlvR2dWeXNNYl9pb29JZHZN?oc=5" target="_blank">FDA clears Endogena's IND for GA investigational compound</a>&nbsp;&nbsp;<font color="#6f6f6f">Glance by Eyes On Eyecare</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNOWVvZHI5LWpxX3J0T2lTeGVoVXNLdG5nQXMwX05IUklZdzNPcTU1cU5HNXNWcms5d3RaUUtFRlpYa0RLSkQ4RGxpTXFvTVFqSURIZzBIVlFRRi1OZERhb2h4cnI2UWtfUUxOblFoZFBsUllHdTFVZkFXSXdIMDNjTHM4NVZyNXM5elczVXprSUp1RWFNeU5ramVvNU1DTEVqOVdfMg?oc=5" target="_blank">First Patient Receives Investigational Treatment Under Right to Try Law</a>&nbsp;&nbsp;<font color="#6f6f6f">Cure Today</font>
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQOGdvZ0VxdUM4Z1MxQ3lSMHl6dDZONlNUV050SjRuZnQ3MFNMQ3pwMktMRVkyM21MTTlWSTk1XzJCbU12aXlqRTNGMXZOWDFqUlY0WFczOWQ2azBEUHRtOHN0TmJzRUdzUy1oenRWSW1ORUZYQVR5ZVdBWVpJQXNtRjlqVEZNY0I0VDVSSTgzc3Y2YVRBMjI2MjdUWDJUa0ZIWnZWcnRoeVpzSjMzcXJ2dlBn?oc=5" target="_blank">Investigational cancer compound receives FDA approval to begin human trials</a>&nbsp;&nbsp;<font color="#6f6f6f">The Pennsylvania State University</font>
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1EQnU2T3BSN1lQRkxocmVYRDYxc0FsV1pQRWtnRWVLRXgzWUQ5bGJleVM0UmJ0aUwxMVVBQUFMWXBZNkQ3RThIVUFocHJoVEhQWnJyRC1OTXNZb1BSUGJzN296Y1RzaE9wYkVrWGR3?oc=5" target="_blank">Demand for Unapproved Weight-Loss Drug Surges on Social Media</a>&nbsp;&nbsp;<font color="#6f6f6f">MedPage Today</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNajFQM2RMenRZUnVaVmM0b0FzWkdjY29xTjZ4b1FBYnVhNC16ZXJNeEswbkJSNVJHS3NNREpTVjNTRjdsX21iSVlMdjRtSzBrUy16cWZWMWo0MG5ORnF5VnZXQXdDOUFPbDRlMnZmZGpzTHlZUkRWRl9rVEtvekZxWE9OeUN2WXZzQ3ZrQzh4UTZCRTVtUWN6M3hQSm4zR0NPeVRGTlhiM3BwR2s?oc=5" target="_blank">Altemia Shows Promising Results in Phase 2 Trial for SCD Children</a>&nbsp;&nbsp;<font color="#6f6f6f">Sickle Cell Disease News</font>
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOaVVySTdxc0xFd0hTbHBVaFphY19vSEVhRFV6THlFVTVTRHIyd1hwQUJTZXlNczl0NThYZ1ZoaFZNcnpLdFpJeTQ2Ti1LblBaM2VZczViYlZiZVIwdkVUMGJaa0ozRmd3YkJGUm1kd19lTExlbDViNm9sYzB0cGxEcjZ1bGlwVk1ZVEZmRjJnR0hZbUYyb3FmQVBjY0ZMbWo1bXFSUG9ZbFlDNVFR?oc=5" target="_blank">Scientists uncover mechanism of action for promising cancer compound</a>&nbsp;&nbsp;<font color="#6f6f6f">UNC Health</font>
<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxPczNETDgyWVV4d3NHLWExMXg2NjVvd21HbFN5Y2k0a2l4U3M4aGQ3TEc4dEV1c09jTHJzSF9hMjJxZ3VEWlFJd212eVh5dEVLUDFYTzNGNXp6VmExWTlOb1FPeEhfZktLWllXakNYd00yYmFQS3BXdy1xTFpxU3JiWVZoTFpSNWZ4UlVzWDJGSXRLanFyWW5USWcwYlUwXy16VWRsd09LRUdTQ2NwZHdsOXZPNVlneUVTVWNEN2cyblVzalQ1MkxScjBpSnJ2cEJ1Ul9BQzNUR01kZHhUQTBDVmJHWHNfbzZzckpVY0RDX3VUbHNsZFp2cUdQak5rUGVKcjhIQzhCM2daekdLeWtOOGZXOA?oc=5" target="_blank">Altos Biologics completes patient enrollment in global Phase 3 clinical trial of Eylea biosimilar in neovascular age-related macular degeneration</a>&nbsp;&nbsp;<font color="#6f6f6f">Ophthalmology Times</font>
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPMDZCNFlNSnJYanNub0U4aWZCZmdTSmxMSVhKOFFhZGVPbVhSQzFUVUZCdjFBSi1qbzJGbFRFRTg4TTVSQ0pVRU5rUWdRazFmZVNSNzhsZDVuS285eFVpbFZrMVZEajBtbTdPMUlTV0ZsRFRyNDdIZUhFaUNNWHZWb3NzSkNKbVc3TkxJTmpEb0dUNkVZX0NQdkFlY1hkRFZaVWlYSFhpR21Ld3QybERIX0tGOXJHM21NNHhnVlF6b21Qdmc4S2FZWHFnUzU?oc=5" target="_blank">Animal research finds investigational drug disrupts MASH by targeting gut-liver axis</a>&nbsp;&nbsp;<font color="#6f6f6f">Managed Healthcare Executive</font>
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPSDF0ZTZHUDhJbDFoc2pMUzRkM2hrZ0F5SmhmZmR0enJsTzhCUXBrbzhOUDRjOUsyU1o5R3FuREZfVWV3R1ZmLVU2V1pWNW5wWm5zMVAtWDlyY0JDMXdCdU1LNXVMZUJSWFJxdkVjbWtpNUsyZHRzYjBJdV9zQ3JZVmpjUENvd2xfanhjNHE4Xy03MFNzaVFpOWNtNG1BOWRORnJvcHVMb0dYWE53dGNEd2VOMTJhMEhQWWdGa3FvbGdtMk15M3pUUVlBUlJ1QlJCV3c?oc=5" target="_blank">FDA Clears MicuRx’s IND for MRX-5, Paving the Way for Phase 2a Trial in Hard-to-Treat NTM Lung Disease</a>&nbsp;&nbsp;<font color="#6f6f6f">Contagion Live</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQR2FkdkFmSnc3UHAyOHhDZFNZLWRoN0RHQmtpMmlmMkZodUlvclNoRlRXYmtKR0FRaVN3S282dXNKRktHWURZZS04Z1JNaTBLaWFZLUpia2hFTm9mbm1jTUg0Ynh1YzR2UUlXdG4tY0VZNVFacFR5dGlXYXBmU1djZ2J3T0dTNldzNElaRS0wQTV5Qi1tWWNlQmZrWGtQaTA3NnhwVVM2U0hTX00?oc=5" target="_blank">Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer</a>&nbsp;&nbsp;<font color="#6f6f6f">Diagnostic and Interventional Cardiology</font>
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNOUxHdWYxUFBuSkd1a2pmaHhuTm5OOVRSYVExWVFvMEdkcTRLd2ljMzdMbm9XV0V3b0hWUEVpbEhjWFRfaDZMWkVYZ09EYkI0LU9jQ0Vpc21KYUc1VzNBMy1QekU1eWx2NFhLOVpWcTZXUURaak1uRnNkdTRYbzdIQk1QT2JHSXBfYW1RQnpZT2VObzNxNkVHTEdDYUhOb3BDVzlBWm40clVGd3dBc0tWZ2cwRVNITkEzSUdtbV9ERGYtT09VOFBF?oc=5" target="_blank">Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults</a>&nbsp;&nbsp;<font color="#6f6f6f">Contemporary Pediatrics</font>
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbGhNZVRIOUoyQ2pCVEdpMjFta1NUX2hrVS1sSGFRYnZLSWNWY1k3XzczNEdyLU84WlV6bXA2RzFIc0lVVXNsbENzbHNzVXFNMzJ0ampHaWsxbWg5ZmNSMzRSU0t5NFFnS3ZlQjRhLTR0US13VTduUldQYWlFUG9STkI4TmpqYWVCNlI1c0pmNXQxRFFINm50Yk4tVzBsazVDek01d2FVbHg2V3hlelhUTHZPMkJuR01fb3JJS0tIeUVGMGJqX1RrZ3UxdURmOUpVaHc?oc=5" target="_blank">Zhittya Genesis Medicine to Enter Phase 1 Clinical Trials in Mexico</a>&nbsp;&nbsp;<font color="#6f6f6f">Parkinson's News Today</font>
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxPUVZwQnQxaVR4RFJ4Z0l4QW5vdEhCTFBvdGNTRFdtNlVxaXZEeWt5X3YxMHk0Q3dGSXh4bzg1UHVWcGpfN1pXQVlZX3hDeWdvX3RnNmY0WkNGQ0w3NWhubVJXdXBBVUk5WW5yMEx2TlBVRTR6X01LMTVlbVRLOE5vUFMzc3VGRGhPaFVBc0NhNGo0NGdlVjBybzh1MHZLeUkzbzk3M3h5QWhuVmx1aDlMcmMxa3VPZndDcFlEdzR2Z1Vyc2hab2JVQlhvODNENTBVX0o4?oc=5" target="_blank">FDA accepts new drug application for investigational compound Dapagliflozin for the treatment of type 2 diabetes</a>&nbsp;&nbsp;<font color="#6f6f6f">AstraZeneca</font>
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT3hUWUMxSUszY3hLSDBzY1k1Q19lVGJMcy04a2JaYnQ3Tjd2SFAxMHprZmpRaWtBeVhMT2lvOUtsT2EzYTRZRjRGclJfWXU4akZmbVpzeWVGT3NEcWIwek9MZDJieTBPa2tCNENIM0lDZHVKUUIzNWxpUzYxN0RJWTlYQTQ5WjhENDlOWS1tMFF3MGRVUklCS0dZV09LNzJiSlVWSDc1dmY?oc=5" target="_blank">Merck inks supply deal with U.S. for investigational COVID-19 therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">drugdiscoverytrends.com</font>
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxONnFpTkdMT05jVHZlNW9kWWpSeTJ2bEs4enI2T1VpMC1HWEVSVTl4TENCV29INWZ3ZnlsT0Zfd0owQnFlTGJ2cnFabzdSckNpSTVjN3pVUkdQalJsWU9acEhZUmxmWjBmQ1pDRy1RcHdaRm44eG12aWtqZl9xSE5MTV9RYzlMeG14OXE0MV92blpiZ0R3RmJwRTd0X3ViYzVHTWlZdmNzQTdPX091ZXdRSnFTaEY1ZU5jdWMzaHNnVDFvLTN4bmJHcmdkRExzX19EMlJCV0E1ckZLclhEM0VB?oc=5" target="_blank">FDA Advisory Committee makes recommendation on investigational compound dapagliflozin</a>&nbsp;&nbsp;<font color="#6f6f6f">AstraZeneca</font>
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQTUVFWm4yNlJyazNvQ3NtUW5rQ1RNaWFUWVZpUDNHQ095Y1RUR2k3VGNNRVhXbWJyb2Q1Sk5fQVZuem1RMDh2Y0lBbUoxY1pfZVVHYlNFMm9uVkR5OWlIYTMzRWNEdUEzdkhzbG9BZWEyc3hGNXVDSU1TaHJJR2V2U2VKWjBoenRxZHlBOENmNjc?oc=5" target="_blank">Novel Compound GPX-150 Shows Promise in Soft Tissue Sarcoma</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxObnV4bVU1aUFXTWhlZ1Nla1ZiMUwzeURJUElPNk8wWHF2cERPc0t3V2pVc1oyLU5UVWlMdFd4a1dMSDFiam9aNldLbFMwTXl4aHh2aElKcDBVTC1aM2RudjJKdGhIZnJWdUJyTDN5a2p5bXAyUTktWm9mZW1NbFF4ZC1mT0JCV21YRmplTEJDS1ZQMzcxTUJfOWctVmo1MDdBVWJkVm9DWi1LUXI2bms1dDd2UTk?oc=5" target="_blank">Boehringer Aces Phase III Pulmonary Fibrosis Trial, Plans FDA Application</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQRFFWd0JuWnA1NTJDTWRmWTFDTTczSF9JbjZBWUR0TVZsWHJJeUlwTDhYal8tMElYdEozSDNmYUVTVE8wbGktRGRMVU1ydWZyYkVJc0E5M20yakR4Q3JNU0paX2pCWWdnYnZWRUgzdXhGYXlyVlZsWk5MZU9nWXVmLTM2aGJrS0NYbGE0cFdQbw?oc=5" target="_blank">Bial Showcases Parkinson’s Research at MDS 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMinwJBVV95cUxNV3poNnd2aDB1SFBfeGpkSjRxR2FJOG5Tam5YMjJqUjh2UlhkUmRDMVhNSkg4VTNZT0JHOWpFX1Q1MHdiMlB6dEZnVDF5UTY1bWllSWdPS2tIRm9IYy1fNkdSSER3UTJNTkJDRVZUTm9ZaVVNRXZTZy02dWppVmpjY0sxUl8yMVZMa3RHcVN1UGdTTVJ2SUpKeDk2ZlJIXzI4VVVCbHhFODhxSDZDLTV1bDhaTjhvemRHdjlZQlZPeERZVUNyZEZpdm5LNTJuSTRFQWEtRHl3UUtrenVPS2hVY2czaUhpcjJvOFFCTHZoeGpKR1FhRlItbXBEcndHMmE4cWJvSmlObkhESFgwemlJNXlHUGhlcEFpQm5GdVlFUQ?oc=5" target="_blank">Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxQejNxUGo0SFZuRE9BRHA3WWZSdzhjX3RTUUlqZUJCaEwzU1RST1BZc2ZPVFZqWGR3OHFaNFNmU0V4N1ZfcXdoUkI0aXY3Zm1hdUN4b19BX2RmMzNuQVJCdmhGT3RNYlBhYkRGUEdtd245RWJrNENIdU9EZTE2MkJqaDhoeGVCdEFYV2lqTjVPZ2lGajhWNzdYMkZNR0tZU1NGUGZwMGtaWkIyX0ZfNlRxbGpBWGJTTEptSXNsQ0lxMkZ0QTgtUkZ3UUppSHVOZlhmdVhzTktmaUd0MmxSbGg3dA?oc=5" target="_blank">Japan Grants Orphan Drug Designation to Eisai’s Novel Orexin Agonist for Narcolepsy</a>&nbsp;&nbsp;<font color="#6f6f6f">Sleep Review</font>
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxQSUVzdjVOb1FiUlJTSVFOdDVhWThRRU1reFBZYzB5MGpkNXBNTVJGT3RzQ20tbVVmaFlQYXkzYjMtZmNfSVd3dHI2ancwMUg5T240MGNKODBwSDlkY1dQb25Fd3RwV1RiME50aUhLV2xQWW1YbXZpQkd0YXIxMUFUSWtJTGJFRF9YOUlpakJXMnViRmNMX3V4Qmk1RDZiTEwtUE5fdF9IYm1IdlFYS21RUWVlNmpnbjM4UXdGdkFhVnNTS2hsOWtxLXBFRVBZS1liS2pIUGZiR1RPRm4ya2VkbWdlZ3NzQXZJR1pv?oc=5" target="_blank">Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>